| Value | ₹26.00 Cr |
|---|
BSE filing, NSE: NAPL. Summary written from the filing by ALFA Finder's alert engine.
Naturite Agro Products Ltd: key numbers
- Share price
- ₹61.80
- Market cap
- ₹65.46 Cr
- Revenue (annual)
- ₹35.64 Cr
- Net profit (annual)
- ₹-0.75 Cr
- P/E (TTM)
- -89.6×Sector 22.8×
- Promoter holding
- 69.34%+0.29% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Naturite Agro Products Ltd
All →Naturite Agro Products Other Announcement
Naturite Agro Products Ltd has filed its quarterly shareholding pattern for the period ended September 30, 2026, as required under SEBI regulations.
Naturite Agro Products Board Meeting Date
Naturite Agro Products Ltd has scheduled a board meeting on October 12, 2026, to consider a proposal for raising funds through the issuance of securities.
Naturite Agro Products Stock Split
Naturite Agro Products Ltd received confirmation for the new ISIN (INE223R01022) activation, following the sub-division of its equity shares.
Naturite Agro Products Capital Structure Change
Naturite Agro Products has fixed September 25, 2026, as the record date for its approved 1:2 stock split, dividing ₹10 shares into ₹5 shares.
Naturite Agro Products Annual General Meeting
Naturite Agro Products Ltd held its 36th AGM on September 9, 2026. Shareholders approved all agenda items, including financial statements, director appointments, and share split.
Naturite Agro Products Annual General Meeting
Naturite Agro Products Ltd has issued a notice for its 36th Annual General Meeting to be held on September 9, 2026.
Other fund raise announcements
All →Sudarshan Pharma Industries Fund Raise of ₹72 Cr
Sudarshan Pharma's board approved up to Rs. 72 Crore of preferential convertible warrants for promoters Hemal and Sachin Mehta. Shareholder approval will be sought at an EGM.
- Value
- ₹72.00 Cr
Flywings Simulator Training Centre Fund Raise of ₹68.2 Cr
Flywings Simulator's board approved Rs. 68.20 Crore fully convertible warrants on a preferential basis. Promoter Rupal Mandavia is allotted Rs. 25 Crore, subject to shareholder approval.
- Value
- ₹68.20 Cr
Kanel Industries Fund Raise of ₹16.99 Cr
Kanel Industries' board approved a rights issue of 42.52 lakh equity shares at Rs.39.95 each. The issue aggregates about Rs.16.99 Crore, with record date 13 November 2026.
- Value
- ₹16.99 Cr
- Execution
- Rights issue opens 23 November 2026 and closes 30 November 2026
Sudarshan Pharma Industries Fund Raise
Board approved issuing up to 72 Crore warrants to promoters on a preferential basis. Pricing per Reg 164 is pending, with no fixed rupee value stated.
GAIL (India) Fund Raise
GAIL Board approved in principle the IPO of subsidiary GAIL Gas Limited on Indian exchanges. GAIL will dilute its GGL equity up to 25%.
Gujarat Inject (Kerala) Fund Raise of ₹3 Cr
Gujarat Inject Kerala's board approved a Rs.3 Crore preferential warrant issue to public investors. Authorised capital will rise to Rs.17.63 Crore, subject to shareholder approval.
- Value
- ₹3.00 Cr